Hospital Fundación Jiménez Díaz
Psychiatry
Dr.Rodrigo Carmona Camacho is a psychiatrist at Fundación Jiménez Díaz (Madrid, Spain) and associate professor at the Faculty of Psychology of the Complutense University of Madrid (Spain). He has worked in Dual Pathology since 2012, first with a grant from the Spanish Society of Psychiatry that allowed him to work as a research assistant at the Multicultural Mental Health Research Center (Dr. Alegria. Cambridge Health Alliance. Harvard Medical School. Boston, MA) and later as project coordinator and clinical supervisor of the International Latino Research Partnership project (NIDA Grant 5R01DA034952-02). These positions have given him experience in the development and operation of international research networks, fields in which he later obtained his PhD from the Universidad Autónoma de Madrid (2019). His work in the field of dual pathology has focused on minority populations and the use of new technologies in mental health, having developed a specific assessment and treatment tool, which has been tested in pregnant women within the WOMAP project (Woman Mental Heatlth and addictions on pregnancy) funded by the National Plan on Drugs (Ministry of Health. Government of Spain). These works have resulted in several publications and conferences in international forums.

Presenter of 1 Presentation

E-Health Treatments for Dual Disorders on Pregnancy

Session Type
Oral Communication
Date
Mon, 06.06.2022
Session Time
10:00 - 11:30
Room
Hall F
Session Icon
On Demand
Lecture Time
10:16 - 10:24

Abstract

Introduction

Dual pathology during pregnancy, described as the co-occurrence of substance use and mental health problems, is one of the leading preventable causes of maternal and perinatal mortality and morbidity; however, effective and accessible treatments are lacking.

Objectives

As part of the WOMAP(Woman Mental Health and Addictions on Pregnancy) initiative, our study aimed to evaluate the effectiveness of an e-health-based psychotherapeutic program compared to enhanced usual care.

Methods

This effectiveness clinical trial was conducted between 2016-2020 in 5 hospitals in the Madrid (Spain) metropolitan area. 2014 pregnant women under 26 weeks of pregnancy were screened. Eligible participants(n=120) were those who screened positive for co-occurring symptoms (AC-OK screener) and were not receiving specialized behavioral treatment. Participants were assessed in depth at baseline, 2,4,8 and 12 months(PHQ-9;GAD-7;PCL-5;AUDIT;DAST;Fagerström) and randomized to the usual care control group(n=38) or to two groups of a 10-session pregnancy-adapted psychotherapeutic program, one delivered by App/internet(n=41) and one by telephone(n=41). Intent-to-treat analyses assessed effectiveness.

Results

Statistically significant effects of the intervention were found for mental health symptoms in the telephone group as compared to the control and App/internet groups, with an improvement effect starting earlier(2 months) and lasting longer(figures 1-3). Regarding substance use, due to the lack of other substances consumption, only smoking and alcohol cessation rates were analyzed. Patients in the App/internet and telephone groups discontinued significantly more, earlier and for a longer period compared to the control group(figures 4-5).

phq9.jpg

gad-7.jpg

pcl.jpg

tabaco.jpg

alcohol.jpg

Conclusions

E-health psychotherapeutic programs could benefit pregnant women with dual disorders. An App/internet implementation could only be useful if focused solely on substances.

Hide